Literature DB >> 8291575

Foveomacular dystrophy.

J I Lim1, C Enger, S L Fine.   

Abstract

We reviewed the clinical records of 47 patients (92 eyes) at the Wilmer Institute in whom foveomacular dystrophy had been diagnosed between 1977 and 1990 to determine reasons for initial examination, long-term visual prognosis, and the factors associated with visual loss. From each clinical record, we obtained the patient's age at the time first seen, symptoms, initial and final visual acuity, lesion size and appearance, and results of fluorescein angiography, electroretinography, and electro-oculography. The most common reasons for examination were decreased visual acuity in 25 of the 47 patients (53%), metamorphopsia in six (13%), referral for diagnosis in seven (15%), and misdiagnosis of age-related macular degeneration in seven (15%). Over an average follow-up period of 5.0 years, in 29 patients (56 eyes), visual acuity changed less than two lines in 41 eyes and decreased greater than or equal to two lines in 15 eyes. In most patients with foveomacular dystrophy, visual acuity appears to remain relatively stable.

Entities:  

Mesh:

Year:  1994        PMID: 8291575     DOI: 10.1016/s0002-9394(14)73007-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Genetic and phenotypic heterogeneity in pattern dystrophy.

Authors:  P J Francis; D W Schultz; A M Gregory; M B Schain; R Barra; J Majewski; J Ott; T Acott; R G Weleber; M L Klein
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Multimodal imaging of adult-onset foveomacular vitelliform dystrophy.

Authors:  Seanna Grob; Yoshihiro Yonekawa; Dean Eliott
Journal:  Saudi J Ophthalmol       Date:  2014-04

Review 3.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

4.  Adult-onset foveomacular vitelliform dystrophy and indocyanine green videoangiography.

Authors:  M Battaglia Parodi; D Iustulin; D Russo; G Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

5.  Primary intravitreal ranibizumab for adult-onset foveomacular vitelliform dystrophy.

Authors:  Roberto Gallego-Pinazo; Rosa Dolz-Marco; Diamar Pardo-López; J Fernando Arevalo; Manuel Díaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-08       Impact factor: 3.117

6.  Colour vision testing as an aid to diagnosis and management of age related maculopathy.

Authors:  G B Arden; J E Wolf
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

7.  Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports.

Authors:  Young Seob Lee; Eung-Suk Kim; Moosang Kim; Young-Gyun Kim; Hyung-Woo Kwak; Seung-Young Yu
Journal:  BMC Ophthalmol       Date:  2012-07-20       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.